1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with AIDS, Murine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basile, AS; Kustova, Y; Markey, SP; Morse, HC; Nishida, K; Sei, Y; Skolnick, P | 1 |
| Basile, AS; Kustova, Y; Markey, SP; Morse, HC; Nishida, K; Sei, Y | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and AIDS, Murine
| Article | Year |
|---|---|
Increased brain levels of platelet-activating factor in a murine acquired immune deficiency syndrome are NMDA receptor-mediated.
Topics: AIDS Dementia Complex; Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Platelet Activating Factor; Receptors, N-Methyl-D-Aspartate | 1996 |
Pentoxifylline decreases brain levels of platelet activating factor in murine AIDS.
Topics: Animals; Brain; Brain Diseases; Leukemia Virus, Murine; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Pentoxifylline; Phosphodiesterase Inhibitors; Platelet Activating Factor; Retroviridae Infections; Tumor Necrosis Factor-alpha; Tumor Virus Infections | 1997 |